Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 563-567

  Goldfarb, D A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Renal cell carcinoma; Surgery; VHL

Indexed keywords

GADOLINIUM;

CANCER STAGING; CLINICAL FEATURE; CONFERENCE PAPER; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; NEOPLASM STAGING; NEPHRECTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031809312     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00339.x     Document Type: Conference Paper

References (18)

1. Latif F, Tory K, Gnarra J et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993; 260: 1317-20.
2. Poston CD, Jaffe GS, Lubensky IA et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. J Urol 1995; 153: 22-6.
3. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease. sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 1995; 154: 2010-15.
4. Neumann HPH, Zbar B, Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int 1997; 51: 16-26.
5. Steinbach F, Novick AC, Zincke H et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicentre study. J Urol 1995; 153: 1812-6.
6. Neumann HPH. Basic criteria for clinical diagnosis in genetic counselling in von Hippel-Lindau syndrome. J Vasc Dis 1987; 16: 220-26.
7. Maher ER, Yates JR, Harries R et al. Clinical features and natural history of von Hippel-Lindau disease. Quart J Med 1990; 77: 1151-63.
8. Neumann HPH, Eggert HR, Scheremet R et al. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992; 55: 898-901.
9. Choyke PL, Glenn GM, Walther MM et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. Am J Radiol 1992; 159: 1229-34.
10. Robson CJ, Churchill BM, Anderson W, The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297.
11. Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR, Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 1995; 45: 34-41.
12. Hafez KS, Novick AC, Campbell SC. Patterns of tumour recurrence and guidelines for follow-up after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997; 157: 2067-70.
13. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742-7.
14. Peterson GJ, Codd JE, Cuddihee RE, Newton WT. Renal transplantation in von Hippel-Lindau disease. Arch Surg 1977; 112: 841-2.
15. Steinbach F, Novick AC, Shoskes D, Renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Urology 1994; 44: 760-63.
16. Goldfarb DA, Novick AC, Penn I, Neumann HPH. North American and European experience with renal transplantation for patients with renal cell carcinoma and von Hippel-Lindau disease. J Urol 1997; 157: 327.
17. Glavac D. Neumann HPH, Wittke C et al. Mutations in the VHL tumour suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 1996; 98: 271-80.
18. Zbar B, Kishida T, Chen F et al. Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America, Europe, and Japan. Human Mutation 1996; 8: 348-57.